共 85 条
[1]
Cook G.J.(2004)Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging Semin Nucl Med 34 122-133
[2]
Wegner E.A.(2007)Positron emission tomography in oncology: a review Clin Oncol (R Coll Radiol) 19 237-255
[3]
Fogelman I.(2004)Positron emission imaging of head and neck cancer, including thyroid carcinoma Semin Nucl Med 34 180-197
[4]
Wood K.A.(2006)Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer Semin Nucl Med 36 194-205
[5]
Hoskin P.J.(2005)Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I wholebody scanning results? J Nucl Med 46 1164-1170
[6]
Saunders M.I.(1989)Value of post-therapy whole-body 131-I imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose 131-I therapy Clin Nucl Med 14 793-800
[7]
Schoder H.(1988)18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy Eur J Nucl Med 13 502-506
[8]
Yeung H.W.(1996)Fluorine-18 FDG and iodine-131 uptake in thyroid cancer J Nucl Med 37 1468-1472
[9]
Lind P.(2001)Resistance of [18f]-fluorodeoxyglucoseavid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine Thyroid 11 1169-1175
[10]
Kohlfürst S.(2006)Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management J Nucl Med 47 616-624